Revolutionary Treatment for Lupus Sparks Hope: Katie’s Remarkable Journey to Remission

An experimental treatment that resets a malfunctioning immune system has put the disease lupus into remission in early UK trials. This groundbreaking approach could potentially treat similar disorders, such as multiple sclerosis and rheumatoid arthritis. Among the first patients to experience this change is Katie Tinkler, who shared that she has “never been this good” since her diagnosis 30 years ago. Once, she found it hard to walk with her children, but now she can ski and is completely off all lupus medication.

Lupus is a condition affecting approximately 50,000 people in the UK, predominantly women, who make up 90% of those diagnosed. It typically manifests in young adults and sees the immune system mistakenly attacking the body, leading to joint pain, skin conditions, and serious damage to organs like the kidneys. Katie was diagnosed in 1993 at the tender age of 20. She was determined not to let this illness dictate her life and even worked as a fitness instructor. Yet, she always kept a packet of steroids handy, just in case a flare-up struck.

When I met Katie in her vibrant kitchen in Surrey, with a glitterball whimsically hanging from the ceiling, she recounted how flare-ups in her hands would leave her struggling to lift a simple cup of tea. She needed to take medication 45 minutes before getting out of bed each morning, or else the pain would be unbearable. The past decade was particularly brutal as the disease turned more aggressive, leading Katie to endure extended hospital stays. Her condition was wreaking havoc on her heart, lungs, and kidneys, bringing her dangerously close to needing dialysis. “Lupus at its worst was in bed, unable to move, going downhill rapidly, possibly dying…now I’m living,” she told me, exuding a newfound spirit.

Fast forward to a year and a half after her experimental treatment, and Katie is bursting with energy, like a woman reborn. “It’s amazing. I’m living like a normal person, I’m literally saying yes to anything. I sort of forgot that you could feel this good,” she expressed, reveling in her newfound lease on life. The treatment she received at University College London Hospitals involved resetting her immune system by engineering a civil war within it—essentially getting one part to destroy the part that was causing her illness.

This innovative method involves two types of white blood cells—B cells and T cells. While T cells usually protect the body from infections, in lupus, B cells can go rogue and produce harmful antibodies that attack the body. Scientists took millions of Katie’s T cells and modified them in the lab, altering their targeting mechanism so they could now attack the rogue B cells. Once reintroduced into her body, these T cells destroy both the harmful and healthy B cells. But here’s the magic: after a few months, new healthy B cells grow, effectively resetting her immune system.

Katie remembers receiving a letter to her GP beforehand, stating she understood the risks and knew she might die as a result of the treatment. It was a grueling process that also involved chemotherapy to prevent her modified T cells from being rejected. She underwent the treatment in November 2024, and now she is thriving, no longer reliant on any lupus medication, with her organs having made a remarkable recovery. “I can live to an old lady with these kidneys and that is phenomenal. My heart’s much better, my lungs much better. My blood disorder is no longer there,” she declared.

Of the first six patients treated, five remain in remission, while one has shown improved symptoms but experienced a lupus flare-up after 11 months. Presenting data at the EULAR European Congress of Rheumatology, the medical team confirmed that their patients have continued to do well after more than 18 months. However, uncertainties linger over how long the treatment’s effects will last and its success in larger trials. Dr. Maria Leandro, a consultant rheumatologist at UCLH, commented to BBC News, “If we were to have patients in remission for three-to-five years consistently, that would be a major gain in lupus; it may be longer than that, but we’ll have to wait and see. This is clearly a significant step forward towards a possible cure, so it is very exciting.”

This revolutionary approach, known as CAR-T or chimeric antigen receptor T-cells, is already an approved treatment for certain blood cancers, including some leukemias and lymphomas. These early results suggest that this method may also be applicable for autoimmune diseases, many of which operate similarly to lupus. Dr. Claire Roddie, from UCL, expressed her excitement about the potential of CAR-T therapy for autoimmune diseases, mentioning conditions like multiple sclerosis and rheumatoid arthritis, which affects a vast number of patients.

Katie, although unsure how long her remission will last, is seizing every opportunity. “I want to climb mountains, I’d love to do Kilimanjaro, I’d love to do a triathlon again, I just want to participate and I want to say yes to as many things as I possibly can.” What will her next adventure be? Only time will tell…

Kaynak: Orijinal Haber